1. Home
  2. TOI vs CELU Comparison

TOI vs CELU Comparison

Compare TOI & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TOI
  • CELU
  • Stock Information
  • Founded
  • TOI 2007
  • CELU 2016
  • Country
  • TOI United States
  • CELU United States
  • Employees
  • TOI N/A
  • CELU N/A
  • Industry
  • TOI Medical/Nursing Services
  • CELU Biotechnology: Pharmaceutical Preparations
  • Sector
  • TOI Health Care
  • CELU Health Care
  • Exchange
  • TOI Nasdaq
  • CELU Nasdaq
  • Market Cap
  • TOI 49.1M
  • CELU 42.2M
  • IPO Year
  • TOI N/A
  • CELU N/A
  • Fundamental
  • Price
  • TOI $1.14
  • CELU $1.73
  • Analyst Decision
  • TOI
  • CELU
  • Analyst Count
  • TOI 0
  • CELU 0
  • Target Price
  • TOI N/A
  • CELU N/A
  • AVG Volume (30 Days)
  • TOI 558.9K
  • CELU 162.2K
  • Earning Date
  • TOI 03-24-2025
  • CELU 12-06-2024
  • Dividend Yield
  • TOI N/A
  • CELU N/A
  • EPS Growth
  • TOI N/A
  • CELU N/A
  • EPS
  • TOI N/A
  • CELU N/A
  • Revenue
  • TOI $393,412,000.00
  • CELU $48,200,000.00
  • Revenue This Year
  • TOI $23.95
  • CELU N/A
  • Revenue Next Year
  • TOI N/A
  • CELU $233.89
  • P/E Ratio
  • TOI N/A
  • CELU N/A
  • Revenue Growth
  • TOI 21.33
  • CELU 225.94
  • 52 Week Low
  • TOI $0.13
  • CELU $1.00
  • 52 Week High
  • TOI $1.63
  • CELU $5.69
  • Technical
  • Relative Strength Index (RSI)
  • TOI 64.39
  • CELU 50.37
  • Support Level
  • TOI $0.97
  • CELU $1.47
  • Resistance Level
  • TOI $1.34
  • CELU $2.40
  • Average True Range (ATR)
  • TOI 0.17
  • CELU 0.22
  • MACD
  • TOI 0.04
  • CELU 0.05
  • Stochastic Oscillator
  • TOI 63.83
  • CELU 41.74

About TOI The Oncology Institute Inc.

The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services.

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from bio-banking segment.

Share on Social Networks: